BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Read BioWorld's AACR 2026 coverage
Breaking News: Best of BioWorld: Q1
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Lexicon reports phase II data on LX-4211 in type 2 diabetes
Jan. 11, 2011
Bristol-Myers Squibb and AstraZeneca launch Kombiglyze in U.S.
Jan. 11, 2011
Zafgen reports topline phase Ib data on ZGN-433 in obesity
Jan. 10, 2011
Ardea's phase IIb RDEA-594 trial in allopurinol-refractory gout meets endpoints
Jan. 10, 2011
Teva Pharma adds women's health portfolio with acquisition of Theramex
Jan. 10, 2011
Xoma reports interim phase II data on XOMA-052 in type 2 diabetes
Jan. 10, 2011
Vitae Pharmaceuticals describes novel 11-beta-HSD1 inhibitors
Jan. 10, 2011
Santarus and Depomed resume Glumetza distribution in U.S.
Jan. 7, 2011
Insulin PharmFilm is tested in primates
Jan. 7, 2011
New antagonists of melanin-concentrating hormone MCH1 receptor claimed
Jan. 7, 2011
Previous
1
2
…
643
644
645
646
647
648
649
650
651
…
1792
1793
Next
RSS